1 / 6

HITPC - Information Exchange Work Group Meaningful Use Stage 3 Subgroup 1: Quality and Efficiency

HITPC - Information Exchange Work Group Meaningful Use Stage 3 Subgroup 1: Quality and Efficiency. Chair: Dave Goetz Members: Cris Ross, Chris Tashjian , Steve Stack. Goal.

pierce
Download Presentation

HITPC - Information Exchange Work Group Meaningful Use Stage 3 Subgroup 1: Quality and Efficiency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HITPC - Information Exchange Work GroupMeaningful Use Stage 3 Subgroup 1: Quality and Efficiency Chair: Dave Goetz Members: Cris Ross, Chris Tashjian, Steve Stack

  2. Goal • During the call develop initial thinking on administrative simplification and electronic prescribing for Micky to present to the HITPC on August 1.

  3. Every proposed objective should meet two sets of criteria: General MU Criteria and IE WG-specific Criteria General MU Criteria • Supports new model of care (e.g., team-based, outcomes-oriented, population management) • Addresses national health priorities (e.g., NQS, Million Hearts) • Broad applicability (since MU is a floor) • Provider specialties (e.g., primary care, specialty care) • Patient health needs • Areas of the country • Promotes advancement -- Not "topped out" or not already driven by market forces • Achievable-- mature standards widely adopted or could be widely adopted by 2016 IE WG-specific criteria • What overall health information exchange objective do we want to accomplish in Stage 3? • Current IE WG policy objective criteria: • Consolidate our gains • Make HIEeasy • Advance queryfor continuity of care and administrative simplification

  4. Quality and Efficiency Subgroup Topics: • Administrative simplification • Move ahead • E-prescribing • Await recommendation from MU WG Stage 3 for existing objectives/measures • Consider any new areas to address (controlled substances, mail order pharmacies) • Clinical Decision Support • Await final MU 2 regulations, recommendations from MU WG • Questions: • Can the MU framework effectively be used to address those electronic transactions not currently in Stage 1 or Stage 2 as proposed (admin)? • Which Stage 1 or Stage 2 (proposed) objectives should be expanded? • Are there new objectives that need to be created? • Are there Stage 1 or Stage 2 objectives to be deleted or consolidated?

  5. Administrative Simplification • Which transaction areas could be considered? • Prior authorizations, eligibility checks, claims processing/editing, claims attachments, others? • One proposal put on the table is to focus on areas where the clinical and administrative sides touch. • Which are already addressed in the market? • How would the MU framework address this area? • What would be effective for EHR vendors and providers? • What draw upon the levers available under MU?

  6. Electronic Prescribing • Two new areas discussed in IE WG call: • Controlled Substances • What is the market readiness? • Mail Order Pharmacies

More Related